ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,974Medicare Part D Prescriptions Filled, Including Refills

Rank: 336 out of 1456

$589K Total Retail Price of All Prescriptions

Rank: 346 out of 1456

427 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 427 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,465 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 581 531 1 4
OMEPRAZOLE 343 292 2 5
SIMVASTATIN 295 272 3 2
FUROSEMIDE 292 280 4 7
AMLODIPINE BESYLATE 264 198 5 1
WARFARIN SODIUM 233 221 6 21
DONEPEZIL HCL 219 219 7 29
METFORMIN HCL 196 144 8 8
LISINOPRIL 186 145 9 3
TRAMADOL HCL 184 160 10 17
HYDROCHLOROTHIAZIDE 161 111 11 10
KLOR-CON 10 158 135 12 96
GLIMEPIRIDE 143 124 13 33
POTASSIUM CHLORIDE 143 118 13 15
ATORVASTATIN CALCIUM 142 131 15 11
CARVEDILOL 136 124 16 20
PRAVASTATIN SODIUM 132 126 17 9
LOSARTAN POTASSIUM 128 115 18 16
ATENOLOL 116 105 19 18
CITALOPRAM HBR 116 115 19 22
METOPROLOL SUCCINATE 115 90 21 19
ALLOPURINOL 114 94 22 31
PAROXETINE HCL 110 92 23 67
NEXIUM 96 95 24 23
CLOPIDOGREL 96 85 24 32
ZOLPIDEM TARTRATE 95 64 26 14
PANTOPRAZOLE SODIUM 94 72 27 43
GABAPENTIN 92 76 28 13
TAMSULOSIN HCL 90 90 29 34
PLAVIX 89 80 30 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 73 31 24
FAMOTIDINE 84 80 32 45
RANITIDINE HCL 83 71 33 27
SYNTHROID 83 74 33 37
BENAZEPRIL HCL 80 67 35 57
MELOXICAM 80 75 35 30
DOXAZOSIN MESYLATE 76 54 37 84
DIGOXIN 73 73 38 62
TRAZODONE HCL 72 60 39 47
DILTIAZEM ER 68 68 40 147
METOPROLOL TARTRATE 68 51 40 12
CRESTOR 66 66 42 26
HYDROCODONE-ACETAMINOPHEN 64 46 S3 43 6
SPIRONOLACTONE 64 42 43 73
DILTIAZEM 24HR ER 63 56 45 126
TRIAMTERENE-HYDROCHLOROTHIAZID 61 57 46 201
VENLAFAXINE HCL ER 61 51 46 89
TRIAMTERENE-HCTZ 59 55 48 49
LANTUS SOLOSTAR 59 53 48 120
ESCITALOPRAM OXALATE 58 58 50 74
DICLOFENAC SODIUM 58 46 50 95
AVODART 56 56 52 218
AZITHROMYCIN 53 44 53 44
ISOSORBIDE MONONITRATE ER 53 48 53 60
PREDNISONE 53 31 53 42
METOCLOPRAMIDE HCL 52 52 56 125
TRAVATAN Z 52 42 56 302
DILTIAZEM HCL 50 44 58 223
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.